首页>
外国专利>
TREATMENT OF ENTERAL FEEDING INTOLERANCE AND OTHER CONDITIONS USING ULIMORELIN ANALOGS
TREATMENT OF ENTERAL FEEDING INTOLERANCE AND OTHER CONDITIONS USING ULIMORELIN ANALOGS
展开▼
机译:使用ULIMORELIN类似物治疗肠饲不耐症及其他情况
展开▼
页面导航
摘要
著录项
相似文献
摘要
Enteral Feeding Intolerance (EFI) can be efficaciously treated and loss of muscle mass prevented or slowed by administration of therapeutically effective doses of ulimorelin analog every 8 hours (three times a day). Therapeutic benefit can be obtained from single and consecutive daily dosing, including for periods of up to a week or longer.
展开▼